About University of Iowa Hospitals & Clinics Regulatory Contact 2
Clinical Trials at University of Iowa Hospitals & Clinics Regulatory Contact 2
During the past decade, University of Iowa Hospitals & Clinics Regulatory Contact 2 conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at University of Iowa Hospitals & Clinics Regulatory Contact 2
According to Clinical.Site data, the most researched conditions in "University of Iowa Hospitals & Clinics Regulatory Contact 2" are
"PI3K Pathway Activated Tumors" (1 trials), "Solid Tumor and Hematologic Malignancies" (1 trials) and "Tumors With CDK4/6 Pathway Activation" (1 trials). Many other conditions were trialed in "University of Iowa Hospitals & Clinics Regulatory Contact 2" in a lesser frequency.
Clinical Trials Intervention Types at University of Iowa Hospitals & Clinics Regulatory Contact 2
Most popular intervention types in "University of Iowa Hospitals & Clinics Regulatory Contact 2" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "BKM120" (1 trials), "LEE011" (1 trials) and "MEK162" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of Iowa Hospitals & Clinics Regulatory Contact 2
The vast majority of trials in "University of Iowa Hospitals & Clinics Regulatory Contact 2" are
3 trials for "All" genders.
Clinical Trials Status at University of Iowa Hospitals & Clinics Regulatory Contact 2
Currently, there are NaN active trials in "University of Iowa Hospitals & Clinics Regulatory Contact 2".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in University of Iowa Hospitals & Clinics Regulatory Contact 2,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University of Iowa Hospitals & Clinics Regulatory Contact 2, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".